Bachem

Every May and June, over 100,000 employees from approximately 3,800 companies across the Switzerland pedal to work, contributing to enhanced fitness, team spirit, and sustainable mobility. As a company with many avid bike-riding commuters, Bachem repeatedly participates in the Bike to Work Challenge, Switzerland's largest health and cycling promotion event! 🚴♀️ Now the results are in from our 159 Team Bachem Participants 🚴♂️ 🌟 66'461 km cycled: Our participants have collectively pedaled 66,461 km, equivalent to traveling around the world 1.66 times! 🌟 9'570 kg CO2 saved: This is comparable to the emissions from driving a car for about 40,000 kilometers. 🌟 3'603 cycling days: That's the equivalent of cycling every day for nearly 10 years! A big thank you to our teams and employees participating for their commitment and teamwork. Making a positive impact on their health and our environment! #Bachem #BikeToWork #TeamSpirit #Sustainability

🌟Wir dürfen David Ballmer, Amel Durakovic, Flurin Furrer, Larissa Jost, Tiffany Krause, Leon Meier, Robin Schaub, Matias Vifian Lopez, Nina Wiedmer und Erdolina Zylfaj zu der erfolgreich abgeschlossenen Lehre gratulieren.👏 Ihr habt alle Grossartiges geleistet und wir freuen uns darauf, eure weiteren Erfolge zu verfolgen. Alle unsere Absolventen haben entweder eine Stelle bei Bachem gefunden oder einen anderen spannenden Weg für ihre Zukunft eingeschlagen. Bleibt weiterhin so engagiert und motiviert! ------------------------- 🌟We would like to congratulate David Ballmer, Amel Durakovic, Flurin Furrer, Larissa Jost, Tiffany Krause, Leon Meier, Robin Schaub, Matias Vifian Lopez, Nina Wiedmer and Erdolina Zylfaj on successfully completing their apprenticeships.👏 You have all done a great job and we look forward to following your further successes. All our graduates have either found a job at Bachem or have chosen another exciting path for their future. Stay committed and motivated! #Bachem #Apprentices #Success

Last Friday, despite the rain, 50 determined Bachem employees laced up their running shoes and joined the massive 2'460 strong field at the B2Run Basel. With a lot of energy, resilience and team spirit, they mastered the 5.9 km route along the Birs river and all successfully reached the finish line at the St. Jakob Athletics Stadium. A special shoutout to our fastest runners! 👏👏👏 René von der Stück who blazed through the course in an impressive 22:30 minutes, and Katharina Graf who crushed it in 28:00 minutes. #Bachem #B2RunBasel #Running

The FHNW Students Day "Shape Your Future in Pharma" took place a week ago. As part of the site visits, students from the FHNW, the Karlsruhe Institute of Technology and the Albstadt-Sigmaringen University of Applied Sciences were given insight into the world of peptides and oligonucleotides at Bachem. During a panel discussion, the participants could ask our experts questions and gather impressions from the site tour. Many thanks to all the participants and guides! 🌟👏 #Bachem #ShapeYourFuture #StudentOpportunities #CareerDevelopment

Ice cream for everyone! With these words, our employees found their way to the Bubendorf staff restaurant yesterday. There they were able to enjoy delicious and local ice cream in the midday sun in the best weather - well deserved! ☀️ Many thanks to Dream of Ice from Allschwil and Brüderli Gastronomie AG for the organisation. #EmployeeRecognition #Bachem

📽️ New Video Alert! Dive into the world of large-scale manufacturing for oligonucleotides. 🧪🔬 Watch the presentation by Marco Minuth as we explore innovative solutions and sustainable approaches. Whether you’re in the field of APIs or just curious about oligonucleotide production, this video is a must-watch! 🎥 🔗 Watch the video here: https://lnkd.in/e_A-VJen #Oligonucleotides #APIs #PharmaceuticalManufacturing #ScienceTalks #Bachem

📢 Bachem öffnet seine Türen bei der Industrienacht Regio Liestal! Wir freuen uns, Sponsor und Teil der ersten Industrienacht im Grossraum Liestal zu sein. Am 20. September 2024 laden wir euch herzlich ein, unsere Welt der Peptide und Oligonukleotide zu entdecken. Was erwartet euch? 🔬 Spannende Einblicke: Erfahre mehr über unsere Arbeit und die faszinierende Welt der Peptide und Oligonukleotide. 👩🔬 Labor-Experimente: Tauch ein in unsere Labore und erlebe hautnah, wie wir lebensrettende Moleküle entwickeln und produzieren. ⚗ Interaktive Rundgänge: Begleite uns auf einer Tour durch unsere Einrichtungen und lerne, wie wir Innovationen vorantreiben. 🗓️ Wann? Am 20. September 2024 von 17:00 bis 24:00 Uhr. 🌐 Weitere Informationen zur Industrienacht sind auf der offiziellen Website zu finden: https://lnkd.in/ehYWhxV Wir freuen uns darauf, euch zahlreich bei der Industrienacht zu begrüssen und unsere Leidenschaft für diese komplexen Moleküle mit euch zu teilen! ---------------------------- 📢 Bachem opens its doors at the Industry Night Regio Liestal! We are proud to be the main sponsor and part of the first Industry Night in the greater Liestal area. On September 20, 2024, we cordially invite you to discover our world of peptides and oligonucleotides. What can you expect? 🔬Exciting insights: Learn more about our work and the fascinating world of peptides and oligonucleotides. 👩🔬 Laboratory experiments: Immerse yourself in our laboratories and experience first-hand how we develop and produce life-saving molecules. ⚗ Interactive tours: Join us on a tour of our facilities and learn how we drive innovation. 🗓️ When? On September 20, 2024 from 17:00 to 24:00. 🌐 Further information about the Industry Night can be found on the official website: https://lnkd.in/ehYWhxV We look forward to welcoming you to the Industry Night and sharing our passion for these complex molecules with you! #Bachem #Industrienachtliestal #Peptide #Oligonucleotide

Register now for the upcoming webinar re-run on Supply Chain Security! ⏰ Date: Tuesday, June 11 ⏰ Time: 8:00 am CET / 3:00 pm JST 📍 Register here: https://lnkd.in/etkbDk-t #Pharmaceuticals #SupplyChainManagement #API #SupplyChainRiskManagement #Bachem #Webinar

Presenting two essential GLP-1 analogue APIs: Liraglutide & Semaglutide Both are GLP-1 receptor agonists for treating type 2 diabetes and obesity. Marketed as a GLP-1 analogue, it provides effective weight loss and glycemic control. Our DMF are ready and listed by the FDA! What can you expect from us: ➡️ Smooth Registration Process: Our extensive experience in successfully registering highly purified synthetic peptide drugs ensures a seamless process for generic API. ➡️ ANDA Approval: Our synthesized API are ready for commercialization as a generic product after regulatory approval. 📚 Learn More: Explore Liraglutide: https://lnkd.in/giJnEVYX Explore Semaglutide: https://lnkd.in/gu8B_Apm 🌐 Stay Informed: Read our blog article on the impact of GLP-1 analogues: https://lnkd.in/gyT2xwcq 🚀 Partner with Bachem for Generic Peptide API! #GLP-1 #Obesity #Diabetes #Peptides #Genericdrugs

Thank you to all the attendees at the #USTides event. The enthusiasm for the future of oligonucleotides and peptides was truly inspiring. A special shout-out to our Bachem team for their insightful presentations and engaging workshops. Your expertise helped drive valuable conversations across the entire spectrum of therapeutic development. We're excited to continue pushing the boundaries of science and collaborating with the industry to bring innovative oligo and peptide therapies to patients. #Oligonucleotides #Peptides #Bachem #Therapeutics